Yale researcher Dr. Kurt Schalper, assistant professor of pathology and medicine (medical oncology), who has made major breakthroughs in cancer immunotherapy, received an R37 Merit Award from the National Institutes of Health (NIH). The award — granted to...
Researchers at Yale have found that injury to endothelial cells — the cells lining blood vessels — may be a key driver of COVID-19 severity and death. The findings, published in the June 30 edition of The Lancet Haematology, may help to explain the...
Researchers at Yale have identified a molecule that plays a key role in the body’s inflammatory response to overeating, which can lead to obesity, diabetes, and other metabolic diseases. The finding suggests that the molecule could be a promising...
Yale clinicians report promising results after treating COVID-19 patients at Yale New Haven Hospital (YNHH) with a drug that reduces hyperinflammation in cancer patients undergoing immunotherapy.
The team initially gave the drug, tocilizumab, to the most...
A highly unusual school semester has ended, and the coming summer will be unlike any in memory. Families are forgoing backyard barbeques and block parties; cities and towns have cancelled carnivals and Fourth of July festivities. Travel carries extra...
A site co-founded by two Yale researchers for sharing preliminary medical research called medRxiv (pronounced “med archive”) has become a leading source of scientific discovery related to the COVID-19 pandemic.
Known as a preprint server — an online...
Infants as young as six months old can recognize differences in skin color. By age two and a half, research has shown, children prefer playmates who are similar in race and gender. And as early as age three, they are forming judgments about people based...
A team of Yale researchers has developed a new app, Hunala, that aims to be the “Waze for coronavirus.”
Led by Sterling Professor Nicholas Christakis, a physician and social networks expert, with colleagues in the Yale School of Engineering and Applied...
Two Yale emergency physicians have designed a tool to help clinicians better identify COVID-19 patients whose condition is likely to worsen rapidly and who will need intensive care within 24 hours.
The tool, which uses predictive modeling, is called the ...